15 Sep 2020
An article by Julia Wcislo is one of the ten outstanding articles that have been shortlisted for the 2020 Max Perutz Science Writing Award, the MRC’s annual writing competition.
COVID Stories: Drug Discovery Unit led contributions to worldwide effort to tackle coronaviruses (...01 Sep 2020
Since the end of June, our researchers have been returning to the School of Life Sciences to restart their lab-based research. This work encompasses a diverse range of topics from microbiology to gene regulation and plant sciences to drug discovery. Alongside this, scientists are continuing to contribute to the worldwide efforts to tackle COVID-19. Some projects are progressing while others are just starting up following recent funding awards. What is it like as a scientist working with social distancing and additional measures in place in the research laboratories?
18 Aug 2020
CARE (Corona Accelerated R&D in Europe) is the largest undertaking of its kind dedicated to discovering and developing urgently needed treatment options for Covid-19 The initiative is committed to a long-term understanding of the disease and development of therapies for Covid-19 and future coronavirus threats in addition to urgent efforts to repurpose existing therapies for a potential immediate response
02 Jul 2020
During lockdown, the School of Life Sciences at the University of Dundee was not closed. Work continued albeit on a much smaller scale than usual, with the majority of the ongoing research focussed on coronavirus. Our support staff were absolutely critical in keeping the research complex functioning to allow this important work to happen. As we have entered phase 2 of the Scottish Government’s route map out of lockdown, we look back over the past few months and the challenges that our community in the School encountered and had to overcome.
02 Jun 2020
The University of Dundee’s Drug Discovery Unit (DDU) has received €5 million of funding to develop antiviral treatments for Covid-19 and future coronaviruses.
06 May 2020
The Universities of Glasgow and Dundee have been awarded £225,000 to rapidly screen for potential COVID-19 treatments. The project is funded by the COVID-19 Therapeutics Accelerator, an initiative launched by the Bill & Melinda Gates Foundation, Wellcome, and Mastercard to speed up the response to the COVID-19 pandemic by funding the identification, assessment, development and scale up of treatments.
28 Apr 2020
Back in October 2013 Medicines for Malaria Venture (MMV) selected a compound designed and developed at the Drug Discovery Unit (DDU), University of Dundee to enter preclinical development. In June 2015, the discovery, properties and mode of action of the compound DDD107498 were published in the journal Nature.
16 Apr 2020
The University of Dundee is working with partners around the world as part of an expanding effort to rapidly repurpose existing drugs against Covid-19. An international research network established by Scripps Research centres around ReFRAME, the world’s leading collection of drugs known to be safe in humans. The network of collaborating scientific laboratories is aiming to leverage ReFRAME to find antiviral compounds against the novel coronavirus.
06 Apr 2020
University of Dundee researchers are studying a protein that aids the spread of COVID-19 in the hope of finding ways of blocking its function. The team, from the University’s Medical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) are working in partnership with the Drug Discovery Unit (DDU) to study an enzyme found within the SARS-CoV-2 virus that causes COVID-19 infection.
03 Apr 2020
The University of Dundee has helped establish Scotland’s central COVID-19 testing facility in support of the national response to the coronavirus pandemic. The centre, based at the University of Glasgow, was announced by the UK Government yesterday as part of a series of measures to increase testing and response to the spread of COVID-19 across the UK. It will be opened in collaboration with the Scottish Government and industry experts from BioAscent Discovery Ltd and Dundee’s Drug Discovery Unit (DDU).